Clinical trial
Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in…
NCT00325260 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00325260 |
|---|---|
| Title | Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China |
| Official title | A Randomized, Endpoint-Blind, Parallel Group Study to Demonstrate the Non-Inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Biological |
| Interventions | Influvac, subunit influenza vaccine |
| Enrollment | 900 |
| Start date | Mar 1, 2006 |
| First posted | May 12, 2006 |
| Last update posted | Nov 1, 2006 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: